Literature DB >> 20214595

Measuring glycaemic variation.

Fergus J Cameron1, Susan M Donath, Peter A Baghurst.   

Abstract

The measurement of glycaemic variation (GV) is conceived to be of clinical significance in determining diabetes outcomes. The debate as to the importance of GV has been complicated by studies using various metrics of GV in qualitatively different datasets. The purpose of this review is to discuss the properties of 8 of the more commonly used metrics (M-value, MAGE, "J"-index, CONGA, BG rate of change, ADRR, Lability/HYPO score and GRADE). Comparable metrics that can be used to measure continuous glycaemic measurements (CGM) (SDBGL, "J"-index, MAGE, CONGA, GRADE) were then compared in assessing diabetic and non-diabetic datasets. In non-diabetic conditions there was very close correlation (correlation coefficients >0.92) between SDBGL, MAGE and CONGA, however under diabetic conditions the correlation coefficients of the GV metrics diminished significantly. The varying GV metrics have varying inherent properties depending upon the purpose for which they were designed and should not be seen as being interchangeable. Investigators therefore need to be clear about the nature of their enquiry of GV and choose an appropriate metric.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20214595     DOI: 10.2174/157339910790442592

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  17 in total

1.  Translating glucose variability metrics into the clinic via Continuous Glucose Monitoring: a Graphical User Interface for Diabetes Evaluation (CGM-GUIDE©).

Authors:  Renata A Rawlings; Hang Shi; Lo-Hua Yuan; William Brehm; Rodica Pop-Busui; Patrick W Nelson
Journal:  Diabetes Technol Ther       Date:  2011-09-20       Impact factor: 6.118

2.  Assessing inpatient glycemic control: what are the next steps?

Authors:  Curtiss B Cook; Kay E Wellik; Gail L Kongable; Jianfen Shu
Journal:  J Diabetes Sci Technol       Date:  2012-03-01

3.  The need for identifying standardized indices for measuring glucose variability.

Authors:  Fabiana Picconi; Alessandra Di Flaviani; Ilaria Malandrucco; Ilaria Giordani; Susanna Longo; Simona Frontoni
Journal:  J Diabetes Sci Technol       Date:  2012-01-01

4.  Fear of hypoglycemia: Influence on glycemic variability and self-management behavior in young adults with type 1 diabetes.

Authors:  Pamela Martyn-Nemeth; Laurie Quinn; Sue Penckofer; Chang Park; Vanessa Hofer; Larisa Burke
Journal:  J Diabetes Complications       Date:  2017-01-20       Impact factor: 2.852

5.  The effect of type-2-diabetes-related vascular endothelial dysfunction on skin physiology and activities of daily living.

Authors:  Jerrold Scott Petrofsky
Journal:  J Diabetes Sci Technol       Date:  2011-05-01

Review 6.  Utility of different glycemic control metrics for optimizing management of diabetes.

Authors:  Klaus-Dieter Kohnert; Peter Heinke; Lutz Vogt; Eckhard Salzsieder
Journal:  World J Diabetes       Date:  2015-02-15

Review 7.  Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on Reporting.

Authors:  Oliver Schnell; Katharine Barnard; Richard Bergenstal; Emanuele Bosi; Satish Garg; Bruno Guerci; Thomas Haak; Irl B Hirsch; Linong Ji; Shashank R Joshi; Maarten Kamp; Lori Laffel; Chantal Mathieu; William H Polonsky; Frank Snoek; Philip Home
Journal:  Diabetes Technol Ther       Date:  2017-05-22       Impact factor: 6.118

8.  The minimum frequency of glucose measurements from which glycemic variation can be consistently assessed.

Authors:  Peter A Baghurst; David Rodbard; Fergus J Cameron
Journal:  J Diabetes Sci Technol       Date:  2010-11-01

9.  Glycemic Variability Percentage: A Novel Method for Assessing Glycemic Variability from Continuous Glucose Monitor Data.

Authors:  Thomas A Peyser; Andrew K Balo; Bruce A Buckingham; Irl B Hirsch; Arturo Garcia
Journal:  Diabetes Technol Ther       Date:  2017-12-11       Impact factor: 6.118

10.  Lower glycemic fluctuations early after bariatric surgery partially explained by caloric restriction.

Authors:  S Yip; M Signal; G Smith; G Beban; M Booth; R Babor; J G Chase; R Murphy
Journal:  Obes Surg       Date:  2014-01       Impact factor: 4.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.